ArticleTranslational stroke research2026
Association between Lipid Accumulation Product and 3-Month Functional Outcome after Ischemic Stroke: the Obesity-Stroke Paradox.
Article in Translational stroke research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association between the atherogenic index of plasma trajectory and risk of cardiovascular diseases among hypertensive patients: a prospective cohort study.Cardiovascular diabetology. Endocrinology reports · 2026Article
- Hypertriglyceridemia predicts good neurological outcome after mechanical thrombectomy in patients with acute ischemic stroke due to large-vessel disease.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
To explore the association of lipid accumulation product (LAP) with 3-month functional outcome and etiologic subtypes in patients with acute ischemic stroke. Patients with acute ischemic stroke admitted from July 1, 2020, to June 30, 2022 were enrolled in this study. Initial neurological severity was assessed by the National Institutes of Health Stroke Scale (NIHSS) at admission. Functional outcome was evaluated by the modified Rankin Scale (mRS) at 3 months after ischemic stroke onset. Etiologic subtypes were determined according to the method reported in the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. LAP was calculated by a well-established formula and analyzed by quartiles (Q1-Q4). Multivariate logistic regression analysis was conducted to evaluate the association of LAP quartiles with 3-month functional outcome and etiologic subtypes in patients with acute ischemic stroke. A total of 431 patients with acute ischemic stroke were included in this study. After adjusting for several confounding factors, compared with those in the LAP-Q1 group, patients in LAP-Q3 and LAP-Q4 group had a reduced association with poor 3-month functional outcome [odds ratio (OR): 0.038, 95% confidence interval (CI): 0.004-0.339; OR: 0.014, 95% CI: 0.001-0.158]. Furthermore, patients in LAP-Q3 and LAP-Q4 group showed an increased association with Small-artery occlusion (SAO) subtype (OR: 1.919, 95% CI: 1.075-3.425; OR: 2.322, 95% CI: 1.265-4.262). Elevated LAP levels were associated with favorable 3-month functional outcome in patients with acute ischemic stroke, supporting the concept of the "obesity-stroke paradox". Concurrently, patients with elevated LAP levels were more likely to experience SAO as the etiological subtype of their stroke.
Indexed as
Identifiers
41530484What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.